Neonatal screening for congenital hypothyroidism in Japan

Kanshi Minamitani1, Hiroaki Inomata

  • 1Department of Pediatrics, Teikyo University Chiba Medical Center, Chiba, Japan. kminami@med.teikyo-u.ac.jp

Insights

Newborn screening for congenital hypothyroidism in Japan has dramatically improved intellectual outcomes. Ongoing research addresses challenges like delayed hormone increases and central hypothyroidism detection.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Genetics

Background:

  • Congenital hypothyroidism (CH) can lead to irreversible intellectual disability and failure to thrive if untreated.
  • Early identification and treatment are crucial for preventing severe developmental consequences.
  • Newborn mass screening for CH was implemented in Japan in 1979, with guidelines established in 1998.

Purpose of the Study:

  • To evaluate the impact of newborn mass screening on congenital hypothyroidism outcomes in Japan.
  • To identify ongoing challenges and areas for improvement in CH screening and management.
  • To highlight recent advancements in understanding the molecular basis of CH.

Main Methods:

  • Implementation of a nationwide newborn mass screening program for CH since 1979.
  • Development and application of screening guidelines since 1998.
  • Ongoing molecular-level research into causative genes, etiology, and pathology.

Main Results:

  • Near-universal screening coverage (approximately 100%) of newborns in Japan.
  • Significant improvements in intellectual outcomes for patients with CH, with rare instances of irreversible disability.
  • Identification of persistent challenges including delayed thyroid-stimulating hormone increases, management of latent hypothyroidism, and detection of central hypothyroidism.

Conclusions:

  • Newborn mass screening has been highly effective in preventing severe outcomes of congenital hypothyroidism.
  • Continued research and refinement of screening protocols are necessary to address remaining challenges.
  • Advancements in molecular genetics are enhancing the understanding and potential future management of CH.

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...